
==== Front
Mol Ther
Mol Ther
Molecular Therapy
1525-0016
1525-0024
American Society of Gene & Cell Therapy

S1525-0016(24)00464-7
10.1016/j.ymthe.2024.07.009
Correction
Overcoming effector T cell exhaustion in ovarian cancer ascites with a novel adenovirus encoding for a MUC1 bispecific antibody engager and IL-2 cytokine
Basnet Saru
Van der Heijden Mirte
Quixabeira Dafne C.A.
Jirovec Elise
Grönberg-Vähä-Koskela Susanna A.M.
Clubb James H.A.
Kanerva Anna
Pakola Santeri
Haybout Lyna
Arias Victor
Hemminki Otto
Kudling Tatiana
Zafar Sadia
Cervera-Carrascon Victor
Santos Joao M.
Hemminki Akseli akseli.hemminki@helsinki.fi
∗
∗ Corresponding author akseli.hemminki@helsinki.fi
19 7 2024
07 8 2024
19 7 2024
32 8 28002800
© 2024 The Author(s)
2024
https://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
==== Body
pmcMain text

(Molecular Therapy, 32, https://doi.org/10.1016/j.ymthe.2024.06.029; September 2024)

In the originally published version of this article, Victor Cervera-Carrascon was mistakenly omitted from the author list. Dr. Cervera-Carrascon along with other authors designed the experiments for the study, and him being missing from the author list was the result of an error by the authors who assembled the author list. The authors apologize for any confusion this may have caused, and this error has been corrected in the paper online.
